PRAME-targeting TCR-engineered NK cells
Term · Oncology and biomedicine · MLC-T-ONC-016204
A preparation of natural killer (NK) cells that are engineered to express a T-cell receptor (TCR) specific for the tumor-associated antigen (TAA) preferentially expressed antigen in melanoma (PRAME), with potential antineoplastic activity. Upon administration, the PRAME-targeting TCR-engineered NK cells specifically recognize and bind to PRAME expressed on cancer cells, thereby lysing the PRAME-expressing cancer cells. PRAME is overexpressed by a variety of cancer cell types.
| Identifier | MLC-T-ONC-016204 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | engineered PRAME-TCR NKs; PRAME-targeted TCR NK cells; PRAME-TCR-NK cells; PRAME-TCR-NKs |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-016204",
"term": "PRAME-targeting TCR-engineered NK cells",
"field": "Oncology and biomedicine",
"definition": "A preparation of natural killer (NK) cells that are engineered to express a T-cell receptor (TCR) specific for the tumor-associated antigen (TAA) preferentially expressed antigen in melanoma (PRAME), with potential antineoplastic activity. Upon administration, the PRAME-targeting TCR-engineered NK cells specifically recognize and bind to PRAME expressed on cancer cells, thereby lysing the PRAME-expressing cancer cells. PRAME is overexpressed by a variety of cancer cell types.",
"synonyms": [
"engineered PRAME-TCR NKs",
"PRAME-targeted TCR NK cells",
"PRAME-TCR-NK cells",
"PRAME-TCR-NKs"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/prame-targeting-tcr-engineered-nk-cells/"
}
Record 13,557 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.